Related Experiment Video
Updated: May 16, 2026

06:04
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Multicenter evaluation of Neurelec Digisonic® SP cochlear implant reliability
Luminiţa Rădulescu1, Sebastian Cozma, Casimir Niemczyk
1ENT Department, Rehabilitation Hospital, University of Medicine and Pharmacy "Gr. T. Popa", 14, Pantelimon Halipa Street, 700661 Iasi, Romania. lmradulescu@yahoo.com
Summary
The Digisonic® SP cochlear implant (CI) shows high reliability in both children and adults. This study found a 5-year cumulative survival rate of over 98%, indicating good device performance for long-term hearing restoration.
Area of Science:
- Audiology
- Biomedical Engineering
- Otolaryngology
Background:
- Universal newborn hearing screening enables earlier cochlear implant (CI) detection.
- Increased CI use necessitates long-term device reliability data for informed choices.
- Assessing the latest generation Digisonic® SP CI's performance is crucial.
Purpose of the Study:
- To evaluate the reliability of the Neurelec Digisonic® SP CI in children and adults.
- To determine the 5-year failure rate (FR) and cumulative survival rate (CSR) of this device.
- To provide data supporting clinical and patient device selection.
Main Methods:
- A multicenter retrospective study involving nine CI centers.
- Data collected via questionnaire for 672 patients implanted between 2006 and 2011.
- Calculation of FR and CSR over a 5-year period for Digisonic® SP recipients.
Main Results:
- Overall explantation rate was 2.23% (15/672) over 5 years.
- Device failure accounted for 0.89% (6/672) of explantations.
- The 5-year CSR was high: 98.51% overall, 98.48% in children, and 98.57% in adults.
Conclusions:
- The Digisonic® SP CI demonstrates excellent 5-year reliability in both pediatric and adult populations.
- Low failure rates support its suitability for long-term use in cochlear implantation.
- This study offers valuable independent data for clinicians and patients choosing cochlear implant devices.
